KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Accumulated Expenses (2016 - 2026)

Supernus Pharmaceuticals has reported Accumulated Expenses over the past 15 years, most recently at $107.8 million for Q4 2025.

  • Quarterly Accumulated Expenses fell 36.1% to $107.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $107.8 million through Dec 2025, down 36.1% year-over-year, with the annual reading at $107.8 million for FY2025, 36.1% down from the prior year.
  • Accumulated Expenses was $107.8 million for Q4 2025 at Supernus Pharmaceuticals, down from $108.6 million in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $175.1 million in Q2 2024 and troughed at $70.1 million in Q1 2021.
  • The 5-year median for Accumulated Expenses is $113.1 million (2021), against an average of $120.4 million.
  • Year-over-year, Accumulated Expenses skyrocketed 115.52% in 2024 and then tumbled 55.61% in 2025.
  • A 5-year view of Accumulated Expenses shows it stood at $117.7 million in 2021, then grew by 28.88% to $151.7 million in 2022, then grew by 1.72% to $154.3 million in 2023, then increased by 9.35% to $168.7 million in 2024, then crashed by 36.1% to $107.8 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Accumulated Expenses are $107.8 million (Q4 2025), $108.6 million (Q3 2025), and $77.7 million (Q2 2025).